Related Experiment Videos
Variability within general practitioner prescribing over time
The New Zealand Medical Journal
|March 30, 2000
Summary
General practitioner prescribing shows 9% year-on-year variability in cost and volume. This intra-general practitioner (GP) prescribing variability should be considered in pharmaceutical budget estimates.
Area of Science:
- Health Economics
- General Practice
- Pharmaceutical Policy
Background:
- General practitioner (GP) prescribing patterns exhibit variability over time.
- Understanding this intra-GP prescribing variability is crucial for accurate pharmaceutical budget forecasting.
Purpose of the Study:
- To quantify the intra-GP prescribing variability in New Zealand general practice.
- To analyze variability in prescription volume, total cost, and average item cost over time.
Main Methods:
- Longitudinal analysis of prescription data from two GP samples (regional and national) in New Zealand (1992-94).
- Utilized reimbursement data and PreMeC prescription analysis (PAS) data.
- Employed the coefficient of variation to measure intra-GP variability.
Main Results:
- Median intra-GP variability was 9% for total cost, 9% for volume, and 5% for average item cost (reimbursement data).
- Variability was higher with PAS data: 16% for cost, 17% for volume, and 8% for average item cost.
- Year-on-year variability was estimated at 9% for cost, 9-10% for volume, and 5-6% for average item cost.
Conclusions:
- Intra-GP prescribing variability is a significant factor in pharmaceutical cost and volume.
- Pharmaceutical budget estimates should incorporate an approximate 9% variability.
- Findings highlight the need for dynamic budgeting that accounts for prescribing fluctuations.